Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$517K Buy
2,484
+1,069
+76% +$232K ﹤0.01% 1022
2023
Q2
$289K Sell
1,415
-246
-15% -$51.7K ﹤0.01% 975
2023
Q1
$416K Sell
1,661
-5,745
-78% -$1.3M 0.01% 773
2022
Q4
$1.23M Buy
7,406
+2,121
+40% +$474K 0.01% 695
2022
Q3
$1.06M Buy
5,285
+3,969
+302% +$802K 0.01% 702
2022
Q2
$239K Buy
1,316
+192
+17% +$36.2K 0.01% 882
2022
Q1
$216K Sell
1,124
-105
-9% -$21.3K 0.01% 872
2021
Q4
$291K Buy
1,229
+97
+9% +$22K 0.01% 721
2021
Q3
$234K Buy
1,132
+70
+7% +$15.5K 0.01% 760
2021
Q2
$234K Buy
+1,062
New +$235K 0.01% 721
2021
Q1
Sell
-25
Closed -$5K 976
2020
Q4
$5K Buy
+25
New +$4.75K ﹤0.01% 952
2019
Q1
Sell
-6
Closed -$1K 919
2018
Q4
$1K Buy
+6
New +$803 ﹤0.01% 509

Other funds holding IEX

Pathstone Family Office's IEX Position: Q3 2023 in Review

Pathstone Family Office increased its IDEX (IEX) stake by 76% in Q3 2023, buying an estimated $232K and bringing the position to 2,484 shares worth $517K. The position accounts for ﹤0.01% of the portfolio, ranked #1022.

Pathstone Family Office first reported a position in IEX in Q4 2018 and has held it in 12 quarters since. The position peaked at $1.23M in Q4 2022. 618 funds tracked by Wall St. Rank hold IEX as of Q3 2023.

  • Pathstone Family Office held 2,484 shares of IDEX worth $517K as of Q3 2023.
  • Pathstone Family Office bought 1,069 IDEX shares in Q3 2023, an estimated $232K.
  • IDEX made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1022 holding.
  • Pathstone Family Office first reported a position in IDEX in Q4 2018 and has held it in 12 quarters since.
  • Pathstone Family Office's IDEX position peaked at $1.23M in Q4 2022.
  • 618 funds tracked by Wall St. Rank held IDEX as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.